IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $50,000 | +72.4% | 845 | +39.4% | 0.00% | +50.0% |
| Q1 2020 | $29,000 | -21.6% | 606 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $37,000 | +2.8% | 606 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $36,000 | -7.7% | 606 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $39,000 | -20.4% | 606 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $49,000 | +48.5% | 606 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $33,000 | +6.5% | 606 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $31,000 | -60.3% | 606 | -60.8% | 0.00% | -66.7% |
| Q4 2017 | $78,000 | 0.0% | 1,544 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $78,000 | -10.3% | 1,544 | -10.0% | 0.01% | -12.5% |
| Q2 2017 | $87,000 | +26.1% | 1,716 | 0.0% | 0.01% | +14.3% |
| Q1 2017 | $69,000 | -15.9% | 1,716 | 0.0% | 0.01% | -22.2% |
| Q4 2016 | $82,000 | +86.4% | 1,716 | +42.2% | 0.01% | +50.0% |
| Q3 2016 | $44,000 | – | 1,207 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |